Point of care testing in family practice: common myths debunked.

[1]  Evaluation of a HbA1c point-of-care analyzer. , 2015, Clinical biochemistry.

[2]  S. Song,et al.  Performance evaluation of SD A1cCare as a HbA1c analyzer for point-of-care testing. , 2015, Clinical Biochemistry.

[3]  R. Hopstaken,et al.  Analytical performance, agreement and user-friendliness of six point-of-care testing urine analysers for urinary tract infection in general practice , 2015, BMJ Open.

[4]  Cliodna McNulty,et al.  Narrative review of primary care point-of-care testing (POCT) and antibacterial use in respiratory tract infection (RTI) , 2015, BMJ Open Respiratory Research.

[5]  J. van Pelt,et al.  Validation and evaluation of eight commercially available point of care CRP methods. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[6]  K. Moons,et al.  The cost–effectiveness of point-of-care D-dimer tests compared with a laboratory test to rule out deep venous thrombosis in primary care , 2015, Expert review of molecular diagnostics.

[7]  M. Cowie.  National Institute for Health and Care Excellence. , 2015, European heart journal.

[8]  L. Levin,et al.  Cost consequences of point-of-care troponin T testing in a Swedish primary health care setting , 2014, Scandinavian journal of primary health care.

[9]  D. Cohen,et al.  Multicenter clinical evaluation of the novel Alere™ i Influenza A&B isothermal nucleic acid amplification test. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[10]  Matthew J. Thompson,et al.  Current and future use of point-of-care tests in primary care: an international survey in Australia, Belgium, The Netherlands, the UK and the USA , 2014, BMJ Open.

[11]  E. Lenters-Westra,et al.  Three of 7 hemoglobin A1c point-of-care instruments do not meet generally accepted analytical performance criteria. , 2014, Clinical chemistry.

[12]  Sverre Sandberg,et al.  From biomarkers to medical tests: the changing landscape of test evaluation. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[13]  PhD Sibyl Anthierens MA,et al.  Clinicians’ Views and Experiences of Interventions to Enhance the Quality of Antibiotic Prescribing for Acute Respiratory Tract Infections , 2014, Journal of General Internal Medicine.

[14]  F. Hecht,et al.  Performance of Rapid Point-of-Care and Laboratory Tests for Acute and Established HIV Infection in San Francisco , 2013, PloS one.

[15]  P. Kesteven,et al.  Comparison of D-dimer point of care test (POCT) against current laboratory test in patients with suspected venous thromboembolism (VTE) presenting to the emergency department (ED) , 2013, Journal of Clinical Pathology.

[16]  J. Cals,et al.  Point-of-care tests in general practice: Hope or hype? , 2013, The European journal of general practice.

[17]  R. Hopstaken,et al.  Analytical performance, agreement and user-friendliness of five C-reactive protein point-of-care tests , 2013, Scandinavian Journal of Clinical and Laboratory Investigation.

[18]  Herman Goossens,et al.  Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: a multinational, cluster, randomised, factorial, controlled trial , 2013, The Lancet.

[19]  Matthew Thompson,et al.  Primary care clinicians’ attitudes towards point-of-care blood testing: a systematic review of qualitative studies , 2013, BMC Family Practice.

[20]  A StJohn,et al.  Economic Evidence and Point-of-Care Testing. , 2013 .

[21]  M. Tunik,et al.  Prospective evaluation of point-of-care ultrasonography for the diagnosis of pneumonia in children and young adults. , 2013, JAMA pediatrics.

[22]  Shuhana Perveen,et al.  Point of Care D-Dimer Testing in the Emergency Department: A Bioequivalence Study , 2012, Annals of laboratory medicine.

[23]  Andrew St John,et al.  Economic Evidence and Point-of-Care Testing. , 2013, The Clinical biochemist. Reviews.

[24]  N. Edwards,et al.  Securing the future of general practice: new models of primary care , 2013 .

[25]  Karel G M Moons,et al.  Safe exclusion of pulmonary embolism using the Wells rule and qualitative D-dimer testing in primary care: prospective cohort study , 2012, BMJ : British Medical Journal.

[26]  B. Liang,et al.  Direct-to-consumer disease screening with finger-stick testing: online patient safety risks. , 2012, Clinical chemistry.

[27]  R. Hopstaken,et al.  C-reactive protein point of care testing and physician communication skills training for lower respiratory tract infections in general practice: economic evaluation of a cluster randomized trial. , 2011, Journal of evaluation in clinical practice.

[28]  Len Lichtenfeld,et al.  Overdiagnosed: Making People Sick in Pursuit of Health , 2011 .

[29]  M Billingsley,et al.  Medical-device recalls in the UK and the device-regulation process: retrospective review of safety notices and alerts , 2011, BMJ Open.

[30]  Matthew Thompson,et al.  Medical device recalls and transparency in the UK , 2011, BMJ : British Medical Journal.

[31]  F. V. van Tiel,et al.  Alarmingly poor performance in Chlamydia trachomatis point-of-care testing , 2010, Sexually Transmitted Infections.

[32]  J. Beilby,et al.  The cost-effectiveness of point of care testing in a general practice setting: results from a randomised controlled trial , 2010, BMC health services research.

[33]  G. Mowatt,et al.  Systematic review of the clinical effectiveness and cost-effectiveness of rapid point-of-care tests for the detection of genital chlamydia infection in women and men. , 2010, Health technology assessment.

[34]  J. Treasure,et al.  A randomised controlled trial of cognitive behaviour therapy and motivational interviewing for people with Type 1 diabetes mellitus with persistent sub-optimal glycaemic control: a Diabetes and Psychological Therapies (ADaPT) study. , 2010, Health technology assessment.

[35]  D. Huckle,et al.  Point-of-care diagnostics - is this driven by supply or demand? , 2010, Expert opinion on medical diagnostics.

[36]  Geert-Jan Dinant,et al.  Point-of-Care C-Reactive Protein Testing and Antibiotic Prescribing for Respiratory Tract Infections: A Randomized Controlled Trial , 2010, The Annals of Family Medicine.

[37]  Tanya K Bubner,et al.  Point-of-care testing for patients with diabetes, hyperlipidaemia or coagulation disorders in the general practice setting: a systematic review. , 2010, Family practice.

[38]  J. Beilby,et al.  Does point‐of‐care testing lead to the same or better adherence to medication? A randomised controlled trial: the PoCT in General Practice Trial , 2009, The Medical journal of Australia.

[39]  Patrick M M Bossuyt,et al.  Using the Principles of Randomized Controlled Trial Design to Guide Test Evaluation , 2009, Medical decision making : an international journal of the Society for Medical Decision Making.

[40]  K J M Janssen,et al.  Excluding venous thromboembolism using point of care D-dimer tests in outpatients: a diagnostic meta-analysis , 2009, BMJ : British Medical Journal.

[41]  Jeroen G Lijmer,et al.  Proposals for a Phased Evaluation of Medical Tests , 2009, Medical decision making : an international journal of the Society for Medical Decision Making.

[42]  Kerenza Hood,et al.  Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial , 2009, BMJ : British Medical Journal.

[43]  J. Beilby,et al.  The point of care testing in general practice trial , 2009 .

[44]  F. Wood,et al.  General practitioners’ perceptions of introducing near-patient testing for common infections into routine primary care: A qualitative study , 2008, Scandinavian journal of primary health care.

[45]  Larry J Kricka,et al.  Improving healthcare accessibility through point-of-care technologies. , 2007, Clinical chemistry.

[46]  Sarah Lord,et al.  When Is Measuring Sensitivity and Specificity Sufficient To Evaluate a Diagnostic Test, and When Do We Need Randomized Trials? , 2006, Annals of Internal Medicine.

[47]  Paul Glasziou,et al.  Comparative accuracy: assessing new tests against existing diagnostic pathways , 2006, BMJ : British Medical Journal.

[48]  E. Messing,et al.  Detection of bladder cancer using a point-of-care proteomic assay. , 2005, JAMA.

[49]  P. Bossuyt,et al.  Randomised comparisons of medical tests: sometimes invalid, not always efficient , 2000, The Lancet.

[50]  S. Murray,et al.  Assessment in primary care : practical issues and possible approaches , 1998 .

[51]  D. Fitzmaurice,et al.  A review of near patient testing in primary care. , 1997, Health technology assessment.

[52]  M F Burritt,et al.  Point-of-care testing. , 1995, Mayo Clinic proceedings.

[53]  S. Murray,et al.  Listening to local voices: adapting rapid appraisal to assess health and social needs in general practice , 1994, BMJ.